se of Nifedipine to treat menstrula pai

Not Applicable

Conditions: Primary Dysmenorrhoea

Registration Number: SLCTR/2013/020

Lead Sponsor: Department of Obstetrics & Gynaecology, Faculty of Medical Sciences, University of Sri Jayewardenepura

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Not specified

Target Recruitment: 39

Inclusion Criteria

1. Patients who are having clinically Primary Dysmenorrhoea (ICD-10, N94.4)
2. Non pregnant women in reproductive age group

Exclusion Criteria

1. Known secondary cause for dysmenorrhoea
2. Current history, examination and investigations suggestive of a secondary cause for dysmenorrhoea
3. Pelvic pain in between menstrual periods
4. Previous pelvic surgery
5. Contraindications for Nifedipine
6. Hypertension (essential or secondary)
7. Contra indications for Mefenemic Acid
8. Any other chronic pains and conditions that might affect the quality of life such as migraine
9. Use of hormonal contraception
10. Use of other forms of treatment for dysmenorrhoea including Ayurvedic and herbal medicine
11. Women with palpitations
12.Women with cardiac diseases
13. Women who are lactating

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Experience of pain due to dysmenorrhoea (using a visual analogue scale)<br><br>2. Quality of life (SF 36 questionnaire, validated in English, Sinhala and Tamil) <br><br>3. Any side effects attributable to the treatment (using a specific structured questionnaire [1.At the end of each day of the cycle: by the patient<br><br>2.At the end of each menstrual cycle by the patient)<br><br>3.At the end of each regime (3 menstrual cycles): by the investigator]<br>

Secondary Outcome Measures